Daniel GoldmanSell
IBRX · Transaction Mar 6, 2023 · Filed Apr 17, 2023 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · IBRX
-0.39% · -$0.0300 · Vol Not reported
Pre-market · updated 06:33:22 ET
Immunitybio Inc
Biotechnology
$7.76
Veridion Score
BETAHIGH CONF · 6/6 factorsFri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET · IBRX
MethodologyIBRX
Immunitybio Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
SELL BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
32/ 100
Veridion Score
SELL BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is IBRX moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Immunitybio Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Listed since
2021
Employees
691
Country
US
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$7.79
Last session
Day high
$7.79
Last session
Day low
$7.79
Last session
Previous close
$7.79
52W high
$11.55
-32.81% from high
52W low
$1.98
60% of range
Market cap
$8.3B
EPS
$-1.0100
Beta
1.20
Shares out
1.1B
Avg volume
8.6M
VWAP
$7.79
Last session
Price history computed in-house
1W
-2.02%
1M
+9.30%
3M
-2.02%
1Y
+235.93%
YTD
+291.92%
SMA 50 $7.73 · above
SMA 200 $6.30 · above
52W position 60%
IBRX overview
Related filings and maps
Public disclosures
Congress activity in IBRX
Official filing ↗
Federal contracts
IBRX contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IBRX in this window.
Lobbying spend
IBRX lobbying filings, year to date.
Registered lobbying filings matched to Immunitybio Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IBRX in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for IBRX.
Options
Sovereign unlock shows live options positioning for IBRX.